Pennsylvania HB1715 amends the Newborn Child Testing Act to include screening for Duchenne muscular dystrophy in the Newborn Child Screening and.

Pennsylvania HB1715 amends the Newborn Child Testing Act to expand the Newborn Child Screening and Follow-up Program. The bill adds Duchenne muscular dystrophy to the list of diseases for which newborn children are screened. This expansion aims to assist health care providers in determining necessary treatments or services to prevent intellectual disability, physical disability, or death. The changes will take effect 60 days after the act's approval.

Pennsylvania HB1715 amends the Newborn Child Testing Act to include screening for Duchenne muscular dystrophy in the Newborn Child Screening and.

Pennsylvania HB1715 amends the Newborn Child Testing Act to expand the Newborn Child Screening and Follow-up Program. The bill adds Duchenne muscular dystrophy to the list of diseases for which newborn children are screened. This expansion aims to assist health care providers in determining necessary treatments or services to prevent intellectual disability, physical disability, or death. The changes will take effect 60 days after the act's approval.